Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Singh

Showing results (41-50 of 263) with videos related to

Pageof 27
Sort By:
The National Medical Journal of India|January 5, 2002
Pandits (priests) as links in improving the reproductive health of women: an alternative strategyM M Singh, P C Joshi
Neuropsychobiology|January 1, 1978
Nosological and prognostic distinctions in schizophrenia: pharmacological validation in terms of therapeutic antagonism between anticholinergic anti-parkinsonism drugs and neurolepticsM M Singh, S R Kay
Lancet (London, England)|September 25, 1976
Letter: Gluten and schizophreniaM M Singh, S R Kay
The Journal of the Association of Physicians of India|January 1, 1971
Severe hypoglycaemic shock caused by chlorpropamide. (Case report)M P Mehrotra, M M Singh
Comprehensive Psychiatry|September 1, 1973
Kinetics and dynamics of response to haloperidol in acute schizophrenia--A longitudinal study of the therapeutic processM M Singh, J M Smith
Indian Journal of Psychiatry|April 2, 2011
Awareness about psychiatry in undergraduate medical students in NepalR K Chadda, M M Singh
Psychopharmacologia|August 21, 1975
A longitudinal therapeutic comparison between two prototypic neuroleptics (haloperidol and chlorpromazine) in matched groups of schizophrenics. Nontherapeutic interactions with trihexyphenidyl. Theoretical implications for potency differencesM M Singh, S R Kay
The British Journal of Psychiatry : the Journal of Mental Science|August 17, 1999
The beginning and end of psychiatric pathwaysS C Pradhan, M M Singh
Biological Psychiatry|February 1, 1979
Cognitive abnormality in schizophrenia: a dual-process modelS R Kay, M M Singh
Neuropsychobiology|January 1, 1979
Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological modelM M Singh, S R Kay
Pageof 27

Showing results (41-50 of 263) with videos related to

Sort By:
Pageof 27
The National Medical Journal of India|January 5, 2002
Pandits (priests) as links in improving the reproductive health of women: an alternative strategyM M Singh, P C Joshi
Neuropsychobiology|January 1, 1978
Nosological and prognostic distinctions in schizophrenia: pharmacological validation in terms of therapeutic antagonism between anticholinergic anti-parkinsonism drugs and neurolepticsM M Singh, S R Kay
Lancet (London, England)|September 25, 1976
Letter: Gluten and schizophreniaM M Singh, S R Kay
The Journal of the Association of Physicians of India|January 1, 1971
Severe hypoglycaemic shock caused by chlorpropamide. (Case report)M P Mehrotra, M M Singh
Comprehensive Psychiatry|September 1, 1973
Kinetics and dynamics of response to haloperidol in acute schizophrenia--A longitudinal study of the therapeutic processM M Singh, J M Smith
Indian Journal of Psychiatry|April 2, 2011
Awareness about psychiatry in undergraduate medical students in NepalR K Chadda, M M Singh
Psychopharmacologia|August 21, 1975
A longitudinal therapeutic comparison between two prototypic neuroleptics (haloperidol and chlorpromazine) in matched groups of schizophrenics. Nontherapeutic interactions with trihexyphenidyl. Theoretical implications for potency differencesM M Singh, S R Kay
The British Journal of Psychiatry : the Journal of Mental Science|August 17, 1999
The beginning and end of psychiatric pathwaysS C Pradhan, M M Singh
Biological Psychiatry|February 1, 1979
Cognitive abnormality in schizophrenia: a dual-process modelS R Kay, M M Singh
Neuropsychobiology|January 1, 1979
Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological modelM M Singh, S R Kay
Pageof 27